Shanghai, China and Pittsburgh, September 8, 2004 . . .  Shanghai AnXing Scientific Instrument & Materials Import & Export Co., Ltd. (AnXing) of Shanghai, China and Cellomics, Inc. of Pittsburgh, Pennsylvania, U.S.A. announced today that Anxing will be the distribution partner for Cellomics in China.  Anxing will provide sales, marketing, service and customer support for Cellomics products, which include the ArrayScan® and KineticScan® HCS Readers, BioApplications image analysis software, a suite of High Content Informatics (HCi™) software and a portfolio of HitKit® HCS Reagent Kits.These products are used in Drug Discovery and Systems Biology research in pharmaceutical, biotechnology and academic institutions.

“High Throughput cellular analysis and High Content Screening (HCS) are high growth technologies in China as illustrated by last week’s announcement by the National Center for Drug Screening,” stated Mr. Chen Rong, General Manager of Anxing.  “We are excited about our new distributorship with Cellomics as they are recognized globally as the market leader in these technologies.”

“Our new partnership with Anxing is a critical element of our growth strategy, to ensure we maintain our market leadership in key new markets such as China.” Commented Daniel J. Calvo, President & CEO of Cellomics, “Anxing is a terrific partner, given their strong position in the Life Science market in China, coupled with an exceptional service and support capability to ensure our new customers can implement our technology.”

About AnXing

Shanghai AnXing Scientific Instruments and Materials Import and Export Co. Ltd. is established with the approval of the Shanghai Foreign Trade and Economics Committee. The company is also a commissioner of the Shanghai Association of Biopharmaceutical Industry and a member of the Shanghai Association of Foreign Trade. The mission of Anxing is to provide with the market the latest technology as well as equipments for bio-science and bio-technic. From the establishment, we have been making efforts to find total solutions for both researchers and industries. We push our product pipeline through laboratory automation to large scale processing. In order to provide the best proposal we also found our own strong technical support team. Moreover we have been collaborating with the market leaders from all over the world. In the future, Anxing Instruments will continue to act as tie between the technology and users any try to facilitate the development Chinese bio-tech industry.

About Cellomics

Cellomics, Inc. is automating drug discovery through a unique, cell-based assay platform that addresses the needs of Drug Discovery and Systems Biology groups by offering complete systems for High Content Screening.  The platform includes HCS instrumentation (both fixed end-point and kinetic systems), informatics, cellular image analysis software (BioApplications), fluorescent reagents, kits, cell lines, and multiparametric assays.  When applied to early drug discovery, this platform is proving to reduce the 'idea-to-discovery' cycle time in drug discovery, while increasing the probability of the therapeutic success of leads as well as enhancing throughput in systems biology and basic research. Cellomics’ proprietary platforms, including the ArrayScanand KineticScanHCS Readers, along with BioApplications software and High Content Informatics suite, are in use at multiple sites within all of the top fifteen pharmaceutical companies, as well as leading pharmaceutical and biotechnology companies and academic centers globally. For more information about Cellomics, visit our website at www.cellomics.com.

For further information, contact: